NYSE: ZTS · Life Sciences · 4 alerts · CIK 1555280
Share price
$84.39Close, Nov 16
Market cap
$34.3B
Shares outstanding
406.32MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Zoetis Inc. filings on SEC EDGAR ↗
Zoetis Inc. reported revenue of $2,391 million for the third quarter of 2026, a slight decrease from $2,422 million in the prior year period. Net income attributable to Zoetis Inc. for the quarter was $591 million, down from $721 million in 2025, primarily driven by higher restructuring charges and other deductions.
Zoetis reported third-quarter 2026 revenue of $2.4 billion, a 1% decrease compared to the prior year, driven by macro-driven price sensitivity and competitive pressure in the U.S. companion animal segment. The company narrowed its full-year 2026 revenue guidance and raised its adjusted EPS guidance, citing confidence in its innovation pipeline and livestock growth.
Term
Q3 2026
“Our third-quarter performance was in line with our expectations. Continued pressure in Companion Animal was partially offset by growth in Livestock and Diagnostics, reflecting the breadth of our portfolio.”
Kristin Peck, Chief Executive Officer of Zoetis
“We remain focused on defending our position and directing our resources where they can have the greatest impact. And with the scale, expertise, and pipeline to keep setting the pace of innovation in animal health, we are confident in our ability to create long-term value for customers and shareholders.”
Zoetis Inc. appointed Iris Knobloch to its Board of Directors, effective December 1, 2026, increasing the board size from twelve to thirteen members. Ms. Knobloch, who currently serves as President of the Festival de Cannes and on the boards of Lazard and Vail Resorts, will also serve on the Board’s Corporate Governance Committee.
Zoetis Inc. declared a fourth quarter 2026 cash dividend of $0.53 per share. The dividend is scheduled to be paid on December 1, 2026, to shareholders of record as of October 30, 2026.